Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 14 Prostatic Neoplasms 12 Multiple Myeloma 8 Neoplasm Metastasis 6 Osteoporosis 4 Carcinoma, Renal Cell 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Lung Neoplasms 2 Kidney Neoplasms 2 Bone Diseases 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Osteonecrosis 1 Oligodendroglioma 1 Neovascularization, Pathologic 1 Neoplasms by Site 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Micrometastasis 1 Nasopharyngeal Neoplasms 1 Myelodysplastic Syndromes 1 Mesothelioma 1 Lymphoma 1

Interventions

Denosumab 3 gentamicin-polymethylmethacrylate bead 1 fludarabine 1 aldesleukin 1 Zoledronic Acid 1 Vitamin D 1 Nivolumab 1 Ipilimumab 1 Dasatinib 1 Cyclophosphamide 1 Calcium 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Giant Cell Tumor of Bone × Zoledronic Acid × Clear all

NCT00889590 2016-01-26

HR-GCT

Leiden University Medical Center

Phase 2 Terminated

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon ⚡